Dados B3 › ONCO3
ONCO3 (Oncoclínicas do Brasil): has profit grown?
ONCO3 (Oncoclínicas do Brasil): in 2025, net loss was R$ 3.6 billion, a loss in both years versus 2024 (a loss of R$ 646.2 million); five years earlier (2020), a loss of R$ 159.6 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | -R$ 3.6 billion | a loss in both years |
| 2024 | -R$ 646.2 million | a turn from profit to loss |
| 2023 | R$ 223.6 million | up 383% |
| 2022 | R$ 46.3 million | a turn from loss to profit |
| 2021 | -R$ 46.9 million | a loss in both years |
| 2020 | -R$ 159.6 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/ONCO3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: ONCO3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:14 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:14 UTC. If this does not match /saude, you are reading a cached copy.